BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 4903794)

  • 1. Clofazimine (Lamprene) in leprosy.
    Drug Ther Bull; 1970 Jan; 8(2):7-8. PubMed ID: 4903794
    [No Abstract]   [Full Text] [Related]  

  • 2. Bacteriological effect of Lamprene (clofazimine) in lepromatous leprosy (report of one year's treatment of 44 patients with 100 mg of Lamprene daily).
    Leiker DL; Blenska W; Carling D; Fitzherbert M; Larssen P
    Lepr Rev; 1971 Jun; 42(2):125-30. PubMed ID: 4948481
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies of experimental chemotherapy of leprosy.
    Banerjee DK
    Lepr India; 1976 Oct; 48(4 Suppl):686-9. PubMed ID: 800233
    [No Abstract]   [Full Text] [Related]  

  • 4. Activity of phenazine analogs against Mycobacterium leprae infections in mice.
    Van Landingham RM; Walker LL; O'Sullivan JF; Shinnick TM
    Int J Lepr Other Mycobact Dis; 1993 Sep; 61(3):406-14. PubMed ID: 8228439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapeutic trials in leprosy. 6. Pilot study of the riminophenazine derivative B.663 in low dosage (100 mgm. twice weekly) in the treatment of lepromatous leprosy.
    Waters MF
    Int J Lepr Other Mycobact Dis; 1968; 36(4):391-9. PubMed ID: 4898403
    [No Abstract]   [Full Text] [Related]  

  • 6. The killing of Mycobacterium leprae in mice by various dietary concentrations of clofazimine and ethionamide.
    Gelber RH
    Lepr Rev; 1987 Dec; 58(4):407-11. PubMed ID: 3323753
    [No Abstract]   [Full Text] [Related]  

  • 7. Clofazimine in leprosy.
    Schulz EJ
    Br Med J; 1972 Mar; 1(5802):749. PubMed ID: 5015339
    [No Abstract]   [Full Text] [Related]  

  • 8. Double-blind controlled clinical trial of clofazimine in reactive phases of lepromatous leprosy.
    Karat AB; Jeevaratnam A; Karat S; Rao PS
    Br Med J; 1970 Jan; 1(5690):198-200. PubMed ID: 4904935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study of skin pigmentation by clofazimine.
    Levy L; Randall HP
    Int J Lepr Other Mycobact Dis; 1970; 38(4):404-16. PubMed ID: 5534493
    [No Abstract]   [Full Text] [Related]  

  • 10. Clofazimine-resistant leprosy, a case report.
    Warndorff-van Diepen T
    Int J Lepr Other Mycobact Dis; 1982 Jun; 50(2):139-42. PubMed ID: 6749703
    [No Abstract]   [Full Text] [Related]  

  • 11. Forty-four months' experience in the treatment of leprosy with clofazimine (Lamprene (Geigy)).
    Schulz EJ
    Lepr Rev; 1971 Sep; 42(3):178-87. PubMed ID: 5151819
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of B.1912, a new riminophenazine derivative in murine leprosy.
    Chang YT
    Int J Lepr Other Mycobact Dis; 1970; 38(4):417-21. PubMed ID: 5534494
    [No Abstract]   [Full Text] [Related]  

  • 13. Minimal effective dosages in mice of clofazimine (B,663) and of ethionamide against Mycobacterium leprae.
    Shepard CC
    Proc Soc Exp Biol Med; 1969 Oct; 132(1):120-4. PubMed ID: 4899207
    [No Abstract]   [Full Text] [Related]  

  • 14. Clofazimine ointment in the treatment of trophic ulcers.
    Ellis BP; Taube E
    S Afr Med J; 1973 Mar; 47(9):378-9. PubMed ID: 4690398
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug resistant-Mycobacterium leprae--results of mouse footpad studies from a laboratory in south India.
    Ebenezer GJ; Norman G; Joseph GA; Daniel S; Job CK
    Indian J Lepr; 2002; 74(4):301-12. PubMed ID: 12624978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Toxicology of the antileprosy drug 3-(para-chloranilino)-10-(para-chlorphenyl)-2,10-dihydro-2-(isopropylimino)-phenazine (G 30 320). Acute and subchronic toxicity, reproduction toxicology].
    Stenger EG; Aeppli L; Peheim E; Thomann PE
    Arzneimittelforschung; 1970 Jun; 20(6):794-9. PubMed ID: 4989740
    [No Abstract]   [Full Text] [Related]  

  • 17. [Employment of a program in the leprosy campaign in Mayotte based on the use of rifampicin and clofazimine].
    Blanchy S; Galtier J
    Acta Leprol; 1982; (88):19-22. PubMed ID: 6818815
    [No Abstract]   [Full Text] [Related]  

  • 18. Single-dose treatment for paucibacillary leprosy; clinical problems and management.
    Pai VV; Bulchand HO; Revankar CR; Ganapati R
    Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):310-2. PubMed ID: 10575414
    [No Abstract]   [Full Text] [Related]  

  • 19. Management of steroid-dependency with clofazimine (Lamprene or B 663 (Geigy)).
    Morgan J
    Lepr Rev; 1970 Oct; 41(4):229-32. PubMed ID: 5515679
    [No Abstract]   [Full Text] [Related]  

  • 20. The antileprotic action of clofazimine (B663, G30, 320, Lamprene).
    Azulay RD; da Silva NC; Zeo A; Portela AB; Franca JC; Peluso LL
    Int J Lepr Other Mycobact Dis; 1974; 42(1):13-8. PubMed ID: 4607163
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.